Home | Investors | ASX Announcements | 2011 ASX Announcements 2011 Date Document 12/12/2011 Newsletter 09/12/2011 Patent Application Lodged for MRI Measurement of Fatty Liver 05/12/2011 Resonance Health appoints Middle East distributor 16/11/2011 Results of Meeting 16/11/2011 Managing Director`s Address to Shareholders 31/10/2011 Appendix 4C - quarterly 17/10/2011 Notice of Annual General Meeting/Proxy Form 17/10/2011 Annual Report to shareholders 28/09/2011 Full Year Statutory Accounts 31/08/2011 Preliminary Final Report 08/08/2011 Appendix 3Y 03/08/2011 FDA clearance to market cardiac iron test in USA 01/08/2011 Change in address of office premises 29/07/2011 Appendix 4C - monthly 23/05/2011 RHT Develops Accurate Fatty Liver Diagnostic Test 29/04/2011 Appendix 4C - quarterly 28/03/2011 Presentation at Small Cap Showcase Expo 2011 10/03/2011 Expands Master Service Agreement with Novartis 25/02/2011 Half Yearly Report and Accounts 11/02/2011 RHT signs agreement with Pfizer 31/01/2011 Appendix 4C - quarterly 21/01/2011 RHT Gains Worldwide Exclusive License 18/01/2011 Response to ASX Query re Appendix 3Z 14/01/2011 FerriScan Reimbursement Update 12/01/2011 Final Director`s Interest Notice
